...Hello, everyone, and welcome to the Biovica Q3 interim report. Today, me, Anders Rylander, the CEO of Biovica; and our CFO, Anders MorTn, will be the presenters. And the agenda will be a short introduction about Biovica, our company, we'll go through the Q3 highlights, and we'll go through the financials, and we'll finish off with a summary from me, and we'll open up for a Q&A session. During the Q&A session, we will invite our analysts to the call to ask questions, but we will also take questions from the chat using the chat function in the event. And don't forget to check the anonymous chat box if you want to remain anonymous. Let's go into a short introduction of Biovica. So Biovica was founded to commercialize our product DiviTum, and DiviTum stands for dividing tumor, which indicates what we are measuring. We're measuring cell proliferation, and as you all know, cell proliferation is what's essential within cancer. That's the way cancer grows. And by measuring cell proliferation, you...
